FindTrial
Sign In

Clinicopathologic analysis of different subtypes of surgically proven pancreatic carcinoma

Clinicopathologic analysis of different subtypes of surgically proven pancreatic carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058234
Enrollment
Unknown
Registered
2022-04-03
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Different subtypes of surgically proven pancreatic carcinoma

Interventions

None listed

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: From January 1, 2008 to December 31, 2021, the patient received surgical treatment in our center and was confirmed to be a rare subtype of pancreatic carcinoma by postoperative pathological diagnosis.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Clinical symptoms;Demographic characteristic;Imaging data;Pathological diagnosis;Complications;Prognosis;—

Countries

China

Contacts

Public ContactFeng Lei

West China Hospital of Sichuan University

743538823@qq.com+86 18780240137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026